cyclin G1 Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin G1 monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin G1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin G1 is a crucial regulator of the cell cycle, playing a significant role in the transition from the G1 phase to the S phase. It is involved in the modulation of cyclin-dependent kinases and has been implicated in various cellular processes, including apoptosis and DNA damage response. The study of cyclin G1 is essential for understanding its contributions to tumorigenesis and potential therapeutic targets in cancer treatment. Cyclin G1 monoclonal antibodies enable researchers to explore the complex interactions between cell cycle proteins and their regulatory pathways. Understanding cyclin G1's role in cellular processes can lead to breakthroughs in cancer research and therapeutic development. Cyclin G1 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge of cell cycle regulation and cancer biology.